Breaking News

Conventus Orthopaedics Raises $20M for Cage Extremity Fracture Repair Therapy

By PR Newswire | May 9, 2017

Will be used to commercialize proximal humerus fracture repair therapy, develop Cage extremity fracture repair indications.

Conventus Orthopaedics Inc., a medical device company dedicated to revolutionizing extremity fracture treatment, announced the completion of a $20 million equity financing. Deerfield Management led the financing which was funded entirely by the existing ownership syndicate. 
The Conventus Cage is an intramedullary implant for the repair of extremity fractures, currently FDA cleared for the treatment of shoulder, elbow and wrist fractures. Early clinical results have been promising as patients have experienced a stable fracture fixation with a quicker recovery period, less pain, improved range of motion, and fewer surgical complications when compared to historical literature for existing fracture repair methods.
Scott Flora, Conventus' executive chairman, said, "The Cage is the future of fracture repair.  We are pleased that our investor syndicate, led by Deerfield, share that vision and continue to provide financial support with a long-term view to realize the full potential of this technology."
"The Cage is a truly innovative technology, poised to disrupt the orthopedic trauma market." said Avi Kometz, M.D., Partner at Deerfield Management.  "The early clinical results have been outstanding, leading us to continue our long-term investment thesis in the company."
  • Loading Orthopedic Devices with Biologics and Pharmaceuticals

    Loading Orthopedic Devices with Biologics and Pharmaceuticals

    Dr. Kevin Nelson, Founder and CSO, TissueGen Inc.||May 19, 2017
    Fiber technology enables the delivery of the therapeutic components via a biodegradable platform that can be implanted.

  • Looking Beneath the Surface

    Looking Beneath the Surface

    Sam Brusco, Associate Editor||May 19, 2017
    Surface treatments seek to improve orthopedic device usability, longevity, and bone integration.

  • Going to Extremes

    Going to Extremes

    Michael Barbella, Managing Editor||May 19, 2017
    The innovation and market value found in extremity solutions is prompting a change of heart among major orthopedic firms.